Frederik Johannes Hansen

8PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer diagnosisHaematological tumoursElectrical energy generation (incl. renewables, excl. photovoltaics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma.

Alara Karabiber, Yong Zhou, Anke Mittelstädt

|Oct 06, 2025
Association between autoimmune disease and colorectal cancer: a retrospective case-control study of 120 876 patients.

Sven Heiko Loosen, Frederik Hansen, Tom Luedde

|Apr 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients.

Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie

|Feb 26, 2025
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.

Paul David, Dina Kouhestani, Frederik J Hansen

|Jun 27, 2024
The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?

Frederik J Hansen, Paul David, Georg F Weber

|Jan 21, 2023
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients.

Frederik J Hansen, Paul David, Marina Akram

Pageof 2

Frequent Collaborators

7 joint publications

Georg F Weber

6 joint publications

Paul David

5 joint publications

Susanne Merkel

3 joint publications

Anke Mittelstädt